Skip to main content

STERIS plc Q2 FY2027 results

  • STE · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$264.32+4.29%Close 13 Nov 2026

STERIS plc reported revenue of $1.59 billion, up 8.8% from a year earlier, net income of $214 million and diluted earnings per share of $2.19 against $1.94 for the second quarter of fiscal 2027 (the three months to 30 Sep 2026).

From its quarterly report, the results first announced on 4 Nov 2026. Compiled and checked by AapWire.

Q2 FY2027 against Q2 FY2026

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

STERIS plc Q2 FY2027 results against the year-ago quarter
MeasureQ2 FY2027Q2 FY2026Change
Revenue$1.59B$1.46B+8.8%
Gross profit$710.8M$645.9M+10.0%
Gross margin44.7%44.2%+0.5 pts
Operating income$294.3M$265.8M+10.7%
Operating margin18.5%18.2%+0.3 pts
Net income$213.7M$191.9M+11.4%
Diluted EPS$2.19$1.94+12.9%
Operating cash flow$289.0M$287.8M+0.4%
Capital expenditure$76.10M$86.50M−12.0%
Free cash flow$212.9M$201.3M+5.8%

Operating KPIs for the quarter

STERIS plc operating KPIs, Q2 FY2027
KPIQ2 FY2027Change on a year
Product revenue$816.9Mup 9.6%
Service revenue$771.7Mup 7.9%
Capital equipment revenue$1.7Mdown 19.0%
Healthcare revenue$1.1Bup 8.6%
AST revenue$295.6Mup 5.0%
Life Sciences (revenue)$170.6Mup 17.7%
United States revenue$1.2Bup 9.2%
Ireland revenue$26.0Mdown 4.8%

Earlier quarters

STERIS plc results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q2 FY202730 Sep 2026$1.59B+8.8%$2.19
Q1 FY202730 Jun 2026$1.49B+7.3%$2.04
Q4 FY202631 Mar 2026$1.59B+7.3%$2.24
Q3 FY202631 Dec 2025$1.50B+9.2%$1.96
Q2 FY202630 Sep 2025$1.46B+9.9%$1.94
Q1 FY202630 Jun 2025$1.39B+8.7%$1.79
Q4 FY202531 Mar 2025$1.48B+4.3%$1.48
Q3 FY202531 Dec 2024$1.37B+5.6%$1.75

More on STERIS plc: financial statements · revenue · earnings per share

STE's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.